@prefix : <http://www.s-cubed.dk/ZINVESTDEV_T2DM/V1#> .
@prefix pr: <http://www.assero.co.uk/Protocol#> .
@prefix isoC: <http://www.assero.co.uk/ISO11179Concepts#> .
@prefix isoT: <http://www.assero.co.uk/ISO11179Types#> .
@prefix isoR: <http://www.assero.co.uk/ISO11179Registration#> .
@prefix isoI: <http://www.assero.co.uk/ISO11179Identification#> .
@prefix bo: <http://www.assero.co.uk/BusinessOperational#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<http://www.s-cubed.dk/ZINVESTDEV_T2DM/V1>
	rdf:type owl:Ontology ;
.
<http://www.assero.co.uk/EP#5ab0f130-5385-40e2-a55d-8ad631dfa948>
	rdf:type pr:Epoch ;
	isoC:label "Screening"^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#7740bfc3-5866-46bb-85e4-c7174808973c>
	rdf:type pr:Epoch ;
	isoC:label "Supportive Care | Exercise-led Phase"^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#6c9fb19d-2b60-4e58-a7c7-3e8ad08c06c0>
	rdf:type pr:Epoch ;
	isoC:label "Follow-Up | Home-based Phase"^^xsd:string ;
	pr:ordinal "3"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#c9981317-97ea-41ab-9199-a67495251372>
	rdf:type pr:Arm ;
	isoC:label "rtCGM"^^xsd:string ;
	pr:description "Real-time Continuous Glucose Monitoring"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#f856b577-7faf-41b6-892b-bd1abdfbb44c>
	rdf:type pr:Arm ;
	isoC:label "isCGM"^^xsd:string ;
	pr:description "Intermittent scan (flash) Continuous Glucose Monitoring"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/ELE#c8035466-f9b7-4e62-9495-591552733724>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#c9981317-97ea-41ab-9199-a67495251372> ;
	pr:inEpoch <http://www.assero.co.uk/EP#5ab0f130-5385-40e2-a55d-8ad631dfa948> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
.
<http://www.assero.co.uk/ELE#e7cd0536-5ee8-42c0-b3fa-baee40b0990d>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#f856b577-7faf-41b6-892b-bd1abdfbb44c> ;
	pr:inEpoch <http://www.assero.co.uk/EP#7740bfc3-5866-46bb-85e4-c7174808973c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
.
<http://www.assero.co.uk/ELE#08352df5-677d-42c9-a3c1-1bd13aa7942e>
	rdf:type pr:Element ;
	isoC:label "Exercise Led Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#c9981317-97ea-41ab-9199-a67495251372> ;
	pr:inEpoch <http://www.assero.co.uk/EP#7740bfc3-5866-46bb-85e4-c7174808973c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#895b351a-51a8-4a0d-8da2-c0911bac2248> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#19242c9f-1e6d-4c56-80d4-bdb7c46d994f> ;
.
<http://www.assero.co.uk/ELE#61101bb5-d72e-4382-9a88-b63f9200ea8c>
	rdf:type pr:Element ;
	isoC:label "Exercise Led Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#f856b577-7faf-41b6-892b-bd1abdfbb44c> ;
	pr:inEpoch <http://www.assero.co.uk/EP#7740bfc3-5866-46bb-85e4-c7174808973c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#895b351a-51a8-4a0d-8da2-c0911bac2248> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#19242c9f-1e6d-4c56-80d4-bdb7c46d994f> ;
.
<http://www.assero.co.uk/ELE#f1513017-ac1c-4657-ac81-e51e95476f51>
	rdf:type pr:Element ;
	isoC:label "Home-based Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#c9981317-97ea-41ab-9199-a67495251372> ;
	pr:inEpoch <http://www.assero.co.uk/EP#6c9fb19d-2b60-4e58-a7c7-3e8ad08c06c0> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#0b64544c-9853-423a-8ade-2fc8c089025a> ;
.
<http://www.assero.co.uk/ELE#e1b9e8e3-0a06-4554-89f0-556fc775cf13>
	rdf:type pr:Element ;
	isoC:label "Home-based Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#f856b577-7faf-41b6-892b-bd1abdfbb44c> ;
	pr:inEpoch <http://www.assero.co.uk/EP#6c9fb19d-2b60-4e58-a7c7-3e8ad08c06c0> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#0b64544c-9853-423a-8ade-2fc8c089025a> ;
.
:PR
	rdf:type pr:Protocol ;
	isoC:label "ZINVESTDEV Type 2 Diabetes"^^xsd:string ;
	isoT:hasState :PR_RS ;
	isoT:hasIdentifier :PR_SI ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-13T07:47:10+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:acronym "ZINVESTDEV T2"^^xsd:string ;
	pr:title "The aim of this investigator's study is to compare real-time continuous glucose monitoring (rtCGM) and flash glucose monitoring (isCGM) in adult patients with Type 1 or Type 2 Diabetes during a 14-day training program focused on physical activity and over 4 or 6 weeks of follow-up at home"^^xsd:string ;
	pr:shortTitle "ZINVESTDEV"^^xsd:string ;
	pr:studyPhase :PR_TUC3 ;
	pr:studyType :PR_TUC4 ;
	pr:interventionModel :PR_TUC1 ;
	pr:masking :PR_TUC2 ;
	pr:forIndication <http://www.s-cubed.dk/IND_TYPE_2_DIABETES_MELLITUS/V1#IND> ;
	pr:inTa <http://www.s-cubed.dk/TA_M/V1#TA> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#c9981317-97ea-41ab-9199-a67495251372> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#f856b577-7faf-41b6-892b-bd1abdfbb44c> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#5ab0f130-5385-40e2-a55d-8ad631dfa948> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#7740bfc3-5866-46bb-85e4-c7174808973c> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#6c9fb19d-2b60-4e58-a7c7-3e8ad08c06c0> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#abf6dc62-a91c-4e3a-85af-fddcf9bdc0b3> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#e2f3f386-c6f1-415c-9fbf-6d3c5214c1db> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#c9fc11c1-288d-45fe-8f42-3bcc7aa089bc> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#7662726b-c741-4ad9-afc9-8399ee8e8cbf> ;
.
:PR_RS
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
:PR_SI
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZINVESTDEV T2DM"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
:PR_TUC3
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "3"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66737/V38#C66737_C48660> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC4
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "4"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99077/V28#C99077_C98388> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC1
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "1"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99076/V55#C99076_C82639> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC2
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "2"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66735/V4#C66735_C49659> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
<http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724>
	rdf:type pr:Visit ;
	isoC:label "Run-in"^^xsd:string ;
	pr:shortName "Vis#01"^^xsd:string ;
.
<http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630>
	rdf:type pr:Visit ;
	isoC:label "Baseline"^^xsd:string ;
	pr:shortName "Vis#02"^^xsd:string ;
.
<http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13>
	rdf:type pr:Visit ;
	isoC:label "Week 1"^^xsd:string ;
	pr:shortName "Vis#03"^^xsd:string ;
.
<http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95>
	rdf:type pr:Visit ;
	isoC:label "Week 2"^^xsd:string ;
	pr:shortName "Vis#04"^^xsd:string ;
.
<http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb>
	rdf:type pr:Visit ;
	isoC:label "Week 6"^^xsd:string ;
	pr:shortName "Vis#05"^^xsd:string ;
.
<http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b>
	rdf:type pr:Timepoint ;
	isoC:label "TP1"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_1602e639-8dc5-49d4-a53f-0d39f5911c17> ;
	pr:inVisit <http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#9ff98f77-c154-4048-9288-87255b04bd6d> ;
.
<http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6>
	rdf:type pr:Timepoint ;
	isoC:label "TP2"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_dfd264bf-ba30-4879-9d97-ad1c8bad8c3f> ;
	pr:inVisit <http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#96c3a677-4797-46bd-8920-935ee4960c75> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#722ac4be-d42c-45b0-8d3b-62a2eba86b0d> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#e4f0da52-f628-43f2-ab9d-5ea82f5147f3> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#909197ae-54f3-4af3-b6a9-5701b1672868> ;
.
<http://www.assero.co.uk/TP#895b351a-51a8-4a0d-8da2-c0911bac2248>
	rdf:type pr:Timepoint ;
	isoC:label "TP3"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_d42a3fb6-cd8a-49fd-9f0a-21ac20108654> ;
	pr:inVisit <http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#521e9df7-d235-4a1d-9655-333b45ef840c> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#11abb87c-91ee-4153-87c0-3787e8bed0b2> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#d7f4f0e1-74a0-46ca-a193-f60a598b5862> ;
.
<http://www.assero.co.uk/TP#19242c9f-1e6d-4c56-80d4-bdb7c46d994f>
	rdf:type pr:Timepoint ;
	isoC:label "TP4"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_d3d4670d-13f8-4e70-938b-8a3122387abe> ;
	pr:inVisit <http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#fbe6e46e-c4d2-46f0-ac59-0e97da81cb46> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#5ae1857b-3676-4c80-90bd-61b2cb15be1a> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#9f40e040-8b7e-4bda-918d-418a993bbb48> ;
.
<http://www.assero.co.uk/TP#0b64544c-9853-423a-8ade-2fc8c089025a>
	rdf:type pr:Timepoint ;
	isoC:label "TP5"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_382a6ea2-c87d-4f27-8164-e05e1a3771c4> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#5c1b4ee9-156b-47f7-9805-74081967671f> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#fa0414d8-df80-461b-8d88-753e3e811364> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#b885a318-7db1-4922-b910-c56ba2390147> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#48e83a00-c97f-4956-8cf1-535255ceab70> ;
.
<http://www.assero.co.uk/IC#TPO_1602e639-8dc5-49d4-a53f-0d39f5911c17>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "-604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_dfd264bf-ba30-4879-9d97-ad1c8bad8c3f>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_d42a3fb6-cd8a-49fd-9f0a-21ac20108654>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "4233600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_d3d4670d-13f8-4e70-938b-8a3122387abe>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "8467200"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_382a6ea2-c87d-4f27-8164-e05e1a3771c4>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "25401600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/PROBJ#abf6dc62-a91c-4e3a-85af-fddcf9bdc0b3>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ1"^^xsd:string ;
	pr:fullText "To assess the effect of Xanomeline Transdermal Therapeutic System (TTS) on the ADAS-Cog and CIBIC+ scores at Week 24 in participants with Mild to Moderate Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_1/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#60b11690-dd41-4749-a417-9233aaa84248> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#d070a6db-9c66-442d-822d-063fa82af5b3> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#e2f3f386-c6f1-415c-9fbf-6d3c5214c1db>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ2"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_3/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#8c5dc0f1-6466-449c-bb05-f51a663953c0> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#c9fc11c1-288d-45fe-8f42-3bcc7aa089bc>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ3"^^xsd:string ;
	pr:fullText "To document the safety profile of the xanomeline TTS."^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_4/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#25eb0ecd-f059-4178-aee5-68df289342c9> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#b3b04fbb-dcce-4342-b28e-e5d6692806ed> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#fb049cf0-ae86-4588-85d4-d1a3f3463228> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#7eacb880-7f85-43c7-ae26-b14d802abbfe> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#7662726b-c741-4ad9-afc9-8399ee8e8cbf>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ4"^^xsd:string ;
	pr:fullText "To assess the effect of xanomeline TTS on the measure of behavioral/neuropsychiatric symptoms in participants with  Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_5/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#6aec7e33-fbca-49b9-bd17-74ef5fcf5075> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#741c4d2b-7bd0-4b1e-b636-e043ff13170f>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ5"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvements in activities of daily living. Improved scores on the Disability Assessment for Dementia (DAD) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_6/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#7b8ccbbd-8290-4d56-8c38-80b54763ff26> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PREND#60b11690-dd41-4749-a417-9233aaa84248>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP1"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Alzheimer’s Disease Assessment Scale – Cognitive Assessment (ADAS-Cog) 14 total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_1/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#19242c9f-1e6d-4c56-80d4-bdb7c46d994f> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#0b64544c-9853-423a-8ade-2fc8c089025a> ;
.
<http://www.assero.co.uk/PREND#d070a6db-9c66-442d-822d-063fa82af5b3>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP2"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Clinician’s Interview-Based Impression of Change plus caregiver input (CIBIC+)"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_2/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#19242c9f-1e6d-4c56-80d4-bdb7c46d994f> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#0b64544c-9853-423a-8ade-2fc8c089025a> ;
.
<http://www.assero.co.uk/PREND#8c5dc0f1-6466-449c-bb05-f51a663953c0>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP3"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
.
<http://www.assero.co.uk/PREND#25eb0ecd-f059-4178-aee5-68df289342c9>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP4"^^xsd:string ;
	pr:fullText "The proportion of participants with adverse events, serious adverse events (SAEs), and adverse events leading to study intervention discontinuation over the 24-week study intervention period"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_5/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b64544c-9853-423a-8ade-2fc8c089025a> ;
.
<http://www.assero.co.uk/PREND#b3b04fbb-dcce-4342-b28e-e5d6692806ed>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP5"^^xsd:string ;
	pr:fullText "The change from baseline to Week 12 in continuous laboratory tests: Hepatic Function Panel"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_6/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#895b351a-51a8-4a0d-8da2-c0911bac2248> ;
.
<http://www.assero.co.uk/PREND#fb049cf0-ae86-4588-85d4-d1a3f3463228>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP6"^^xsd:string ;
	pr:fullText "The proportion of participants with abnormal (high or low) laboratory measures (urinalysis) during the postrandomization phase"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_7/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#895b351a-51a8-4a0d-8da2-c0911bac2248> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#19242c9f-1e6d-4c56-80d4-bdb7c46d994f> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#0b64544c-9853-423a-8ade-2fc8c089025a> ;
.
<http://www.assero.co.uk/PREND#7eacb880-7f85-43c7-ae26-b14d802abbfe>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP7"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in ECG parameter: QTcF"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_8/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
.
<http://www.assero.co.uk/PREND#6aec7e33-fbca-49b9-bd17-74ef5fcf5075>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP8"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
.
<http://www.assero.co.uk/PREND#7b8ccbbd-8290-4d56-8c38-80b54763ff26>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP9"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the DAD total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0b8cfd31-c075-42c1-a864-4a24f43c681b> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#273ae5bf-950d-4092-afa7-46dac08345c6> ;
.
<http://www.assero.co.uk/STFRM#9ff98f77-c154-4048-9288-87255b04bd6d>
	rdf:type pr:StudyForm ;
	isoC:label "Informed Consent"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/INFORMED_CONSENT_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#96c3a677-4797-46bd-8920-935ee4960c75>
	rdf:type pr:StudyForm ;
	isoC:label "Device Allocation"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/DEVICE_ALLOC_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#722ac4be-d42c-45b0-8d3b-62a2eba86b0d>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#e4f0da52-f628-43f2-ab9d-5ea82f5147f3>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#909197ae-54f3-4af3-b6a9-5701b1672868>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#521e9df7-d235-4a1d-9655-333b45ef840c>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#11abb87c-91ee-4153-87c0-3787e8bed0b2>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#d7f4f0e1-74a0-46ca-a193-f60a598b5862>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#fbe6e46e-c4d2-46f0-ac59-0e97da81cb46>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#5ae1857b-3676-4c80-90bd-61b2cb15be1a>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#9f40e040-8b7e-4bda-918d-418a993bbb48>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#5c1b4ee9-156b-47f7-9805-74081967671f>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#fa0414d8-df80-461b-8d88-753e3e811364>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#b885a318-7db1-4922-b910-c56ba2390147>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#48e83a00-c97f-4956-8cf1-535255ceab70>
	rdf:type pr:StudyForm ;
	isoC:label "Termination Record"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/TERMINATION_DEMO/V1#F> ;
.